Latest Medical News
— But researchers still see potential for high-dose rifampicin-based treatment strategy
Latest in Latest Medical News
More infants with early primary surgery had canonical babbling at 1 year
Conserving energy and increasing recycling are two good ways to begin, they suggest
Phase III trial shows 86% reduction in treated bleeds in hemophilia A and B with inhibitors
PPV increased to as much as 44.6% with combined-biomarker screening of high-risk patients
Phase III trial shows 86% reduction in treated bleeds in hemophilia A and B with inhibitors
PPV increased to as much as 44.6% with combined-biomarker screening of high-risk patients
More in Latest Medical News
Mezigdomide led to 41% response rate in heavily pretreated patients
Test your medical spelling skills
Obesity should not be considered a contraindication for use, say researchers
News and commentary from the psychiatry world
The healthcare industry must learn to cope with demographic decline and other rapid changes
This past week in healthcare investigations
Risk increased with severity of atopic dermatitis across both groups, cohort study shows
Health news and commentary from around the Web gathered by MedPage Today staff
Improved PFS with encorafenib-binimetinib versus encorafenib, but immunotherapy still top option
At recommended dose in people over 65, potentially pro-arrhythmic concentrations predicted in 20%
News and commentary from the world of neurology and neuroscience
